MOSCOW, February 8 (RIA Novosti) - Uzbekistan’s State Joint Stock Concern Uzfarmprom has signed deals with Chinese companies to build pharmaceutical enterprises in the Tashkent region worth a total $26.8 million, an Uzfarmprom representative said on Friday.
Huaian Rich International will build an ethanol manufacturing factory with capacity of 500,000 decaliters a year, as well as a bottle-cap making facility. Investment will total $12.8 million.
Kunmin Pharmaceutical will build a bronchopulmonary medication factory with capacity of 2 million doses, with investment of $14 million.
All the enterprises will be located in the Angren special industrial zone, set up last year, which has a special customs and tax regime.
Add to blog
You may place this material on your blog by copying the link.
In light of the present situation in the Middle East, Russia and Israel find themselves facing common challenges. Under these newly emerging situations, Russia sees its partnership with Israel as a potential asset in resolving acute regional issues. From a Russian perspective, the compatibility of Israeli and Russian interests could contribute to such a partnership.